Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Defesche

Showing results (101-110 of 178) with videos related to

Pageof 18
Sort By:
Circulation Research|July 19, 2014
Mutations in STAP1 are associated with autosomal dominant hypercholesterolemiaSigrid W Fouchier, Geesje M Dallinga-Thie, Joost C M Meijers, et al.
Human Mutation|November 19, 2011
Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl LevelsRoeland Huijgen, Barbara Sjouke, Kelly Vis, et al.
The American Journal of Cardiology|January 27, 2009
Usefulness of genetic polymorphisms and conventional risk factors to predict coronary heart disease in patients with familial hypercholesterolemiaJeroen B van der Net, A Cecile J W Janssens, Joep C Defesche, et al.
Journal of Applied Genetics|February 11, 2010
Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutationsM Chmara, B Wasag, M Zuk, et al.
Atherosclerosis|January 8, 2011
Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatinArash Alipour, Manuel Castro Cabezas, Jan Willem F Elte, et al.
Clinical Biochemistry|March 26, 2009
Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platformRodrigo Alonso, Joep C Defesche, Diego Tejedor, et al.
Clinical Genetics|March 29, 2000
Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in The NetherlandsM P Lombardi, E J Redeker, J C Defesche, et al.
Atherosclerosis|November 14, 2021
Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemiaTycho R Tromp, Arjen J Cupido, Laurens F Reeskamp, et al.
Journal of Clinical Lipidology|September 1, 2016
Children with hypercholesterolemia of unknown cause: Value of genetic risk scoresBarbara Sjouke, Michael W T Tanck, Sigrid W Fouchier, et al.
Clinical Genetics|September 30, 2011
Extreme xanthomatosis in patients with both familial hypercholesterolemia and cerebrotendinous xanthomatosisR Huijgen, A D M Stork, J C Defesche, et al.
Pageof 18

Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Circulation Research|July 19, 2014
Mutations in STAP1 are associated with autosomal dominant hypercholesterolemiaSigrid W Fouchier, Geesje M Dallinga-Thie, Joost C M Meijers, et al.
Human Mutation|November 19, 2011
Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl LevelsRoeland Huijgen, Barbara Sjouke, Kelly Vis, et al.
The American Journal of Cardiology|January 27, 2009
Usefulness of genetic polymorphisms and conventional risk factors to predict coronary heart disease in patients with familial hypercholesterolemiaJeroen B van der Net, A Cecile J W Janssens, Joep C Defesche, et al.
Journal of Applied Genetics|February 11, 2010
Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutationsM Chmara, B Wasag, M Zuk, et al.
Atherosclerosis|January 8, 2011
Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatinArash Alipour, Manuel Castro Cabezas, Jan Willem F Elte, et al.
Clinical Biochemistry|March 26, 2009
Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platformRodrigo Alonso, Joep C Defesche, Diego Tejedor, et al.
Clinical Genetics|March 29, 2000
Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in The NetherlandsM P Lombardi, E J Redeker, J C Defesche, et al.
Atherosclerosis|November 14, 2021
Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemiaTycho R Tromp, Arjen J Cupido, Laurens F Reeskamp, et al.
Journal of Clinical Lipidology|September 1, 2016
Children with hypercholesterolemia of unknown cause: Value of genetic risk scoresBarbara Sjouke, Michael W T Tanck, Sigrid W Fouchier, et al.
Clinical Genetics|September 30, 2011
Extreme xanthomatosis in patients with both familial hypercholesterolemia and cerebrotendinous xanthomatosisR Huijgen, A D M Stork, J C Defesche, et al.
Pageof 18